• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Cytomegalovirus infection and coronary sclerosis after heart transplantation].

作者信息

Loebe M, Schüler S, Spiegelsberger S, Warnecke H, Fleck E, Hetzer R

机构信息

Deutsches Herzzentrum Berlin.

出版信息

Dtsch Med Wochenschr. 1990 Aug 24;115(34):1266-9. doi: 10.1055/s-2008-1065151.

DOI:10.1055/s-2008-1065151
PMID:2167829
Abstract

Serological tests for cytomegalovirus (CMV) after cardiac transplantation were performed at six to eight-week intervals on 26 patients (3 females and 23 males; mean age 46 [15-62] years) with angiographic or ultimately autopsy evidence of coronary atherosclerosis (group 1) and 24 patients (5 females and 19 males; mean age 45 [25-56] years) without coronary disease in the transplanted heart. A positive result meant an at least fourfold increase in CMV IgG titre, demonstration of CMV IgM or direct viral isolation from blood or other body fluid. In 20 patients of group 1 (77%) a CMV infection had occurred after the transplantation, but in only six patients (25%) in the group 2 (P less than 0.0001). These results are interpreted as demonstrating a relationship between CMV infection and rapidly progressive coronary atherosclerosis after cardiac transplantation.

摘要

相似文献

1
[Cytomegalovirus infection and coronary sclerosis after heart transplantation].
Dtsch Med Wochenschr. 1990 Aug 24;115(34):1266-9. doi: 10.1055/s-2008-1065151.
2
The influence of cytomegalovirus infection, confirmed by pp65 antigen presence, on the development of cardiac allograft vasculopathy.通过pp65抗原检测证实的巨细胞病毒感染对心脏移植血管病变发展的影响。
Transplant Proc. 2007 Nov;39(9):2866-9. doi: 10.1016/j.transproceed.2007.09.013.
3
Heart transplantation in Finland 1985-1995.1985 - 1995年芬兰的心脏移植
Ann Chir Gynaecol. 1997;86(2):113-20.
4
CMV antigenemia (the lower matrix protein PP65), a marker for the guidance of antiviral therapy in cytomegalovirus disease after orthotopic heart transplantation.巨细胞病毒血症(较低基质蛋白PP65),原位心脏移植后巨细胞病毒疾病抗病毒治疗指导的一个标志物。
Wien Klin Wochenschr. 1995;107(23):718-22.
5
Successful management of symptomatic cytomegalovirus disease with ganciclovir after heart transplantation.心脏移植术后应用更昔洛韦成功治疗症状性巨细胞病毒病
J Heart Lung Transplant. 1991 Sep-Oct;10(5 Pt 1):656-62; discussion 662-3.
6
[Serologic diagnosis of cytomegalic inclusion disease using the Elisa technic in kidney transplant patients].[运用酶联免疫吸附测定技术对肾移植患者巨细胞包涵体病进行血清学诊断]
Dtsch Med Wochenschr. 1984 Feb 10;109(6):214-6. doi: 10.1055/s-2008-1069169.
7
T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease.针对亚临床巨细胞病毒感染的T细胞免疫可减轻心脏移植疾病。
Circulation. 2006 Oct 10;114(15):1608-15. doi: 10.1161/CIRCULATIONAHA.105.607549. Epub 2006 Oct 2.
8
Primary cytomegalovirus infection in an outpatient setting--laboratory markers and clinical aspects.门诊环境中的原发性巨细胞病毒感染——实验室指标与临床情况
Infection. 2003 Oct;31(5):318-23. doi: 10.1007/s15010-003-3129-y.
9
[Cytomegalovirus infection after heart transplantation. Retrospective analysis of an antiviral CMV prevention].心脏移植术后巨细胞病毒感染。抗病毒预防巨细胞病毒的回顾性分析
Dtsch Med Wochenschr. 2000 Apr 14;125(15):445-51. doi: 10.1055/s-2007-1024260.
10
Role of cytomegalovirus infection in the development of coronary artery disease in the transplanted heart.巨细胞病毒感染在心脏移植术后冠状动脉疾病发生中的作用。
J Heart Transplant. 1990 Nov-Dec;9(6):707-11.

引用本文的文献

1
[Is it possible to reduce CMV-infections after heart transplantation with a three-month antiviral prophylaxis? 7 years experience with ganciclovir].[心脏移植后进行为期三个月的抗病毒预防能否降低巨细胞病毒感染?使用更昔洛韦的7年经验]
Wien Klin Wochenschr. 2004 Aug 31;116(15-16):542-51. doi: 10.1007/BF03217708.
2
Microorganisms in the aetiology of atherosclerosis.动脉粥样硬化病因中的微生物。
J Clin Pathol. 2000 Sep;53(9):647-54. doi: 10.1136/jcp.53.9.647.